Myth-busting: 4 ways life sciences leaders need to rethink value and evidence
Over the last 3 years, Advisory Board has spoken with 150+ executives across the health care ecosystem to understand how they use and view medical evidence, and how the landscape for value is changing. Our research revealed four misconceptions that must reshape life sciences leaders’ evidence strategy and how they respond to customers’ demands for value.
Watch the recording below to:
- Debunk four common misconceptions about today’s value and evidence landscape
- Understand the implications of emerging trends impacting life sciences leaders’ roles
- Identify how to adapt your evidence generation and value messaging strategy to meet evolving customer needs